Chronic Idiopathic Urticaria: Treatment With OmalizumabChronic Idiopathic Urticaria: Treatment With Omalizumab
Learn more about omalizumab, a fully humanized monoclonal antibody which shows promise as a new third-line option for chronic spontaneous urticaria, a common autoimmune skin condition. Skin Therapy Letter
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Dermatology Journal Article Source Type: news
More News: Allergy | Allergy & Immunology | Dermatology | Hives | Learning | Skin | Universities & Medical Training | Xolair